Sofosbuvir 1190307-88-0

• Post Date:

  May 07,2019

• Expiry Date:

  Nov 03,2019

• Detailed Description:

  Cas No. :1190307-88-0 PSI-7977 is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase.

• CAS Registry Number:

  1190307-88-0

• Synonyms:

  ;PSI 7977;Sofosbuvir(cGMP);L-Alanine, N-[[p(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-p-phenyl-5'-uridylyl]-, 1-methylethyl ester;Psi-7977;(S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate;sofosvuvir form6;sovaldi API;sofosbuvir form6;GS-7977;Sopropyl-(2S)-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl]-4-fluoro-3-hydroxy-4-methy-ltetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate;Sofasbuvir;(S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4 dihydropryimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2yl) methoxy)(phenoxy)phosphoryl)amino) propanoate;

• Molecular Formula:

  C₂₂H₂₉FN₃O₉P

• Molecular Weight:

  529.45

• Molecular Structure:

  

• Company:

  Shanghai Neopharm Co., Ltd.     [ China ]          

• Contact:

  Carol Zhu

• Tel:

  021-58826758

• Fax:

  021-58827258

• Email:

  sales@neopharm.com.cn